The Cash-Pay Opioid and the PDMP
A 34-year-old presents at a Georgia pharmacy with a prescription for oxycodone/acetaminophen 10/325, #120, from an out-of-state prescriber, dated yesterday. The patient insists on paying cash, declines insurance, and asks that the prescription not be run through the PDMP 'for privacy.' The pharmacist checks the Georgia PDMP and sees three other opioid prescriptions from three different prescribers filled at three different pharmacies in the past 30 days, plus a benzodiazepine. The patient becomes agitated when asked about the other prescribers and says, 'Just fill it or I'll go somewhere else.' The pharmacist also notes the prescriber's DEA number is from a state where the patient does not appear to reside.
1. May the pharmacist honor the patient's request to skip the PDMP query/report? What are the pharmacist's obligations and red flags here?
Read the worked answer
No. Georgia's PDMP reporting is mandatory for dispensers of schedule II–V controlled substances, and the pharmacist is required to query the PDMP under specified circumstances (e.g., new opioid or benzodiazepine prescriptions, and per Board/DBF rules). The patient cannot opt out of a legally mandated registry report, and 'privacy' is not a basis to omit it. HIPAA permits disclosures required by law, including PDMP reporting.
Red flags present:
- Cash pay to avoid insurance tracking.
- Multiple prescribers/pharmacies in 30 days (doctor/pharmacy shopping pattern).
- Concurrent benzodiazepine - increased respiratory depression risk.
- Out-of-state prescriber with a DEA number not tied to the patient's residence; verify the prescriber is DEA-registered and licensed to prescribe in Georgia or otherwise authorized.
- High quantity (#120) and agitation/pressure at the counter.
The pharmacist must query the PDMP, document the findings, and exercise professional judgment. The pharmacist may refuse to fill if the prescription is not for a legitimate medical purpose in the usual course of professional practice (21 CFR 1306.04). Refusal should be documented and, where appropriate, the prescriber contacted.
2. The pharmacist decides to refuse. What must be documented, and what, if anything, must be reported?
Read the worked answer
Documentation:
- The date/time, the prescription details, and that the PDMP was queried and what it showed.
- The specific red flags and the pharmacist's clinical reasoning.
- That the prescriber was contacted (or attempted) and the outcome.
- The refusal itself and that the patient was informed without confrontation; return the original prescription if requested.
Reporting:
- Georgia does not require the pharmacist to report every refusal, but the pharmacist should follow the pharmacy's policy and may report suspected diversion or prescribing misconduct to the Georgia Drugs and Narcotics Agency (GDNA) and/or the Board. The PDMP data itself is confidential and may not be redisclosed except as authorized.
- Do not report the patient's identity to the PDMP beyond the required dispensing data (there is no dispensing here).
- If the pharmacist believes the prescriber is practicing outside the usual course, a report to the prescriber's licensing board and/or GDNA is appropriate.
Practical: offer the patient a referral to a pain management or addiction resource, and ensure staff know the refusal script to avoid escalation. The pharmacist's duty is to the legitimate medical purpose, not to the patient's preference.